PeptidePedia The community reference

Contributions of BlindSampleBrid

User contributions·57 logged edits·page 1 of 1

Contributions by BlindSampleBrid, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 9,410 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 8,706 +353 add the incorporation year, attributed to the registry record
  2. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 17,493 +1,305 expand §Notability and coverage
  3. 11:19, 21 Jul 2026 (diff | hist) GenScript Peptides 17,835 +2 convert the product range to a table so the documentation column lines up
  4. 17:47, 11 Jul 2026 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 add the cleavage site by residue number
  5. 11:23, 20 Jun 2026 (diff | hist) Dual incretin agonist 5,851 ±0 expand §Beyond GIP and GLP-1
  6. 20:42, 24 May 2026 (diff | hist) Chain of custody 5,157 ±0 m add the cost basis, since it shapes who submits
  7. 01:06, 3 May 2026 (diff | hist) Cold chain 27,220 ±0 rm the shipping recommendation — that is advice, not description
  8. 15:00, 27 Apr 2026 (diff | hist) PolyPeptide Group (Hangzhou) 18,363 ±0 attribute the documentation description to the purchaser reports it comes from
  9. 11:25, 8 Apr 2026 (diff | hist) Talk:Chain of custody 537 +185 /* Direct supplier-to-laboratory shipment */ new section
  10. 16:45, 29 Mar 2026 (diff | hist) Wuhan Wansheng Biotechnology 15,849 ±0 m add the storage and handling guidance the organisation publishes
  11. 00:02, 26 Mar 2026 (diff | hist) Lot traceability 5,317 ±0 m convert the service comparison to a table
  12. 09:40, 11 Feb 2026 (diff | hist) Talk:PolyPeptide Group (Hangzhou) 537 +336 /* A printed trace and a filled vial are not the same object */ new section
  13. 13:40, 15 Jan 2026 (diff | hist) Talk:Chain of custody 611 +139 /* Asymmetry of uncontrolled results */ reply
  14. 04:17, 11 Jan 2026 (diff | hist) Intention-to-treat analysis 4,963 ±0 m expand §Missing data
  15. 15:47, 20 Dec 2025 (diff | hist) Loss on drying 4,874 ±0 correct the resolution formula — the denominator is the sum of the widths
  16. 11:07, 15 Dec 2025 (diff | hist) Beyond-use date 23,108 +969 the example withdrew more than the syringe holds; corrected
  17. 10:40, 24 Nov 2025 (diff | hist) PeptideMeter 4,925 ±0 move a stray full stop inside the reference
  18. 09:59, 24 Nov 2025 (diff | hist) Zhuhai Kerui Biotechnology 11,046 +1,173 add the minimum order quantity for custom synthesis
  19. 02:46, 24 Nov 2025 (diff | hist) Fmoc chemistry 4,618 ±0 typo
  20. 13:25, 4 Nov 2025 (diff | hist) Qingdao Sigma Chemical 15,235 +481 fix a broken wikilink
  21. 07:15, 6 Oct 2025 (diff | hist) Shanghai ERP Biotechnology 6,760 +284 label the reception tally as weak, self-selected evidence at this point of use
  22. 10:41, 19 Sep 2025 (diff | hist) Talk:WuXi TIDES 1,170 +181 /* Where should the ordering facts sit? */ reply
  23. 14:08, 17 Sep 2025 (diff | hist) Talk:WuXi TIDES 537 +463 /* Where should the ordering facts sit? */ new section
  24. 09:18, 3 Sep 2025 (diff | hist) Talk:PolyPeptide Group (Hangzhou) 822 +233 /* Notability, and what a printed chromatogram does and does not establish */ reply
  25. 03:08, 1 Aug 2025 (diff | hist) Sangon Biotech 11,547 +1,893 move a stray full stop inside the reference
  26. 14:54, 29 Jul 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 5,349 +516 add the see-also to the certificate-of-analysis article
  27. 19:20, 13 Jul 2025 (diff | hist) Sangon Biotech 9,654 +873 state which lines are held in regional stock
  28. 14:55, 30 Jun 2025 (diff | hist) Talk:Blind sampling 885 +194 /* Anonymous ordering: does it count as blinding? */ reply
  29. 23:30, 17 Jun 2025 (diff | hist) Custom peptide synthesis 4,548 +36 m add the figure for the lyophilisation cycle and caption it
  30. 23:12, 17 Jun 2025 (diff | hist) SinoPep 1,941 +1,941 N new article: supplier organisation, created after the notability discussion
  31. 11:07, 12 Jun 2025 (diff | hist) Batch number 4,286 +555 m add the second-opinion point: two services, one lot, is a stronger record
  32. 03:51, 2 Jun 2025 (diff | hist) Hubei Jianxiang Bioscience 5,479 +159 add the note that this wiki publishes no score and no league table
  33. 23:21, 11 May 2025 (diff | hist) Certificate of analysis 8,593 +497 m add category for certificates of analysis
  34. 15:47, 9 Apr 2025 (diff | hist) Purity claim inflation 4,595 ±0 state the date range the submitted set covers
  35. 15:23, 6 Apr 2025 (diff | hist) Bachem Holding (Suzhou) 9,744 +751 add the outbound storefront link, marked nofollow and sponsored per the external-links convention
  36. 19:48, 1 Mar 2025 (diff | hist) Sangon Biotech 5,945 +643 expand §Independent testing record
  37. 03:54, 25 Feb 2025 (diff | hist) Reverse-phase HPLC 4,246 ±0 expand §Reading a reported determination
  38. 18:40, 22 Dec 2024 (diff | hist) Counterfeit peptide 2,066 +681 state that the report identifies the sample, not the shipment
  39. 22:53, 17 Dec 2024 (diff | hist) Sangon Biotech 2,171 +38 fix hyphenation per PP:MOS
  40. 09:25, 28 Nov 2024 (diff | hist) Purity claim inflation 2,887 +217 correct the description of the sampling procedure
  41. 14:11, 24 Nov 2024 (diff | hist) SELECT trial 3,502 ±0 attribute the subgroup finding as exploratory
  42. 01:10, 24 Oct 2024 (diff | hist) Bachem Holding (Suzhou) 2,103 ±0 clarify that a registered business scope is a licensing fact, not a quality assurance
  43. 10:04, 23 Oct 2024 (diff | hist) Talk:Blind sampling 1,033 +90 /* Is "almost no" defensible without a count? */ reply
  44. 05:07, 22 Oct 2024 (diff | hist) Guangzhou JEEP Biotechnology 5,372 ±0 add the catalogue size and label it self-reported
  45. 09:12, 21 Oct 2024 (diff | hist) Talk:Blind sampling 400 +169 /* Is "almost no" defensible without a count? */ new section
  46. 21:36, 20 Oct 2024 (diff | hist) Chinese Peptide Company 4,517 +192 m state the city and province of the registered address
  47. 09:52, 15 Oct 2024 (diff | hist) Talk:Hunan Aslsen Technology 822 +278 /* "Verified by" is not a test result */ reply
  48. 05:51, 7 Oct 2024 (diff | hist) Batch number 2,494 ±0 state the method the reporting service uses, since it is not the only one available
  49. 11:55, 4 Oct 2024 (diff | hist) Liquid chromatography-mass spectrometry 2,132 ±0 state that ultraviolet response is not uniform across impurities
  50. 20:27, 13 Sep 2024 (diff | hist) WuXi TIDES 4,401 +179 unpipe a link that did not need piping
  51. 20:56, 2 Sep 2024 (diff | hist) Qingdao Sigma Chemical 2,212 +38 expand §Notability and coverage
  52. 00:37, 22 Aug 2024 (diff | hist) Janoshik Analytical 2,527 +473 split §What a report shows from §What it does not
  53. 09:00, 21 Aug 2024 (diff | hist) Qingdao Sigma Chemical 1,747 +1,747 N create organisation article per PP:VN
  54. 19:03, 24 Jul 2024 (diff | hist) Lot traceability 1,389 ±0 add the cross-link to the traceability article
  55. 22:41, 23 Jul 2024 (diff | hist) Guangzhou JEEP Biotechnology 2,753 +38 expand §Regulatory position and legal status
  56. 17:28, 13 Jul 2024 (diff | hist) Guangzhou JEEP Biotechnology 2,715 ±0 m state the city and province of the registered address
  57. 17:26, 17 Jun 2024 (diff | hist) GLP-1 receptor agonist 1,642 +1,642 N create article — compound stub